In experimental autoimmune encephalomyelitis, BBG-dependent P2 × 7R antagonism resulted in decreased BBB damage with normalized levels of PDGFβR and claudin-5 and pro-inflammatory cytokines, IL-1β, IL-6, and TNF-α [77, 78]. The gene discussed is CLDN5; the disease is experimental autoimmune encephalomyelitis.